From Scientist to Analyst to Strategist: Aharon (Ronny) Gal Talks with Ken Herrmann and Johannes Czernin About Leadership in Multinational Pharma

By sjmartinez • January 18, 2025

Gal AR, Herrmann K, Czernin J. From Scientist to Analyst to Strategist: Aharon (Ronny) Gal Talks with Ken Herrmann and Johannes Czernin About Leadership in Multinational Pharma. J Nucl Med. 2025 Jan 16:jnumed.124.269177. doi: 10.2967/jnumed.124.269177. Epub ahead of print. PMID: 39819691.

Tags: Cardiology/Epi, Publications

Intracoronary acetylcholine for vasospasm provocation in women with ischemia and no obstructive coronary artery disease

Tjoe B, Pacheco C, Suppogu N, Samuels B, Rezaeian P, Tamarappoo B, Berman DS, Sharif B, Nelson M, Anderson RD, Petersen J, Pepine CJ, Thomson[...]

18F flurpiridaz PET MPI: Imaging characteristics and clinical trials

Maddahi J. 18F flurpiridaz PET MPI: Imaging characteristics and clinical trials. J Nucl Cardiol. 2025 Mar;45S:102175. doi: 10.1016/j.nuclcard.2025.102175. Epub 2025 Mar 28. PMID: 40180504.

Mass spectrometric profiling of primary estrogens and estrogen metabolites in human stool and plasma partially elucidates the role of the gut microbiome in estrogen recycling

Li VW, Dong TS, Funes D, Hernandez L, Kushnir NR, Nair D, Jacobs JP, Reddy ST, Mayer EA, Chang L, Meriwether D. Mass spectrometric profiling[...]